Shares of Scholar Rock Holding Co. (NASDAQ:SRRK – Get Free Report) hit a new 52-week high on Monday after HC Wainwright raised their price target on the stock from $40.00 to $50.00. HC Wainwright currently has a buy rating on the stock. Scholar Rock traded as high as $38.74 and last traded at $38.74, with a volume of 253808 shares trading hands. The stock had previously closed at $29.92.
SRRK has been the subject of several other reports. Piper Sandler raised their price objective on Scholar Rock from $28.00 to $42.00 and gave the stock an “overweight” rating in a research note on Tuesday, October 15th. JPMorgan Chase & Co. increased their price target on Scholar Rock from $18.00 to $31.00 and gave the company an “overweight” rating in a research report on Monday, October 14th. Wedbush boosted their price objective on Scholar Rock from $40.00 to $47.00 and gave the stock an “outperform” rating in a report on Monday. BMO Capital Markets raised their target price on shares of Scholar Rock from $34.00 to $38.00 and gave the stock an “outperform” rating in a report on Friday, October 11th. Finally, Truist Financial boosted their price target on shares of Scholar Rock from $36.00 to $45.00 and gave the company a “buy” rating in a report on Monday. Six investment analysts have rated the stock with a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of “Buy” and a consensus price target of $40.43.
Check Out Our Latest Analysis on SRRK
Insider Activity
Institutional Inflows and Outflows
Institutional investors and hedge funds have recently bought and sold shares of the company. Barclays PLC lifted its holdings in shares of Scholar Rock by 103.4% during the 3rd quarter. Barclays PLC now owns 165,449 shares of the company’s stock valued at $1,324,000 after buying an additional 84,118 shares during the last quarter. Geode Capital Management LLC raised its position in Scholar Rock by 8.5% during the third quarter. Geode Capital Management LLC now owns 1,543,025 shares of the company’s stock valued at $12,361,000 after acquiring an additional 120,489 shares in the last quarter. Wellington Management Group LLP lifted its stake in Scholar Rock by 16.2% in the third quarter. Wellington Management Group LLP now owns 199,777 shares of the company’s stock valued at $1,600,000 after acquiring an additional 27,801 shares during the last quarter. Sphera Funds Management LTD. bought a new stake in Scholar Rock in the third quarter worth approximately $1,337,000. Finally, Quarry LP increased its stake in shares of Scholar Rock by 3,443.3% during the 3rd quarter. Quarry LP now owns 4,500 shares of the company’s stock worth $36,000 after purchasing an additional 4,373 shares during the last quarter. Hedge funds and other institutional investors own 91.08% of the company’s stock.
Scholar Rock Stock Down 1.7 %
The firm has a market cap of $3.47 billion, a P/E ratio of -15.83 and a beta of 0.47. The business’s fifty day moving average price is $23.12 and its two-hundred day moving average price is $14.21. The company has a current ratio of 3.88, a quick ratio of 3.88 and a debt-to-equity ratio of 0.63.
Scholar Rock Company Profile
Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery, development, and delivery of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company develops Apitegromab, an inhibitor of the activation of myostatin that is in Phase 3 clinical trial for the treatment of spinal muscular atrophy; and SRK-181, which has completed Phase 1 clinical trials for the treatment of cancers that are resistant to checkpoint inhibitor therapies, such as anti-PD-1 or anti-PD-L1 antibody therapies.
Read More
- Five stocks we like better than Scholar Rock
- High Dividend REITs: Are They an Ideal Way to Diversify?
- Cerence Up 155% in 2 Days: SoundHound AI’s Fierce Competitor
- Retail Stocks Investing, Explained
- Why Warren Buffett Is Selling: A Look at His Latest Market Moves
- What Are Dividend Contenders? Investing in Dividend Contenders
- Why Amazon Shares May Never Trade Below $200 Again
Receive News & Ratings for Scholar Rock Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Scholar Rock and related companies with MarketBeat.com's FREE daily email newsletter.